We are live on
!
Find out more
BC
Bridgefront Capital Portfolio holdings
AUM
$402M
1-Year Est. Return
18.17%
This Fund
S&P 500
This Quarter
Est. Return
+22.27%
1 Year Est. Return
+18.17%
3 Year Est. Return
+38.15%
5 Year Est. Return
+29.06%
10 Year Est. Return
–
AUM
$292M
AUM Growth
–
Cap. Flow
+$274M
Cap. Flow
% of AUM
93.77%
Top 10 Holdings %
Top 10 Hldgs %
7.32%
Holding
582
New
582
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Water Works
AWK
|
+$3.07M |
| 2 |
Dominion Energy
D
|
+$2.59M |
| 3 |
Air Products & Chemicals
APD
|
+$2.16M |
| 4 |
McDonald's
MCD
|
+$2.15M |
| 5 |
Boston Scientific
BSX
|
+$2.04M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 13.88% |
| 3 | Industrials | 12.01% |
| 4 | Consumer Discretionary | 11.46% |
| 5 | Financials | 11.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Entergy
ETR
$54.1B
| $243K | 0.08% |
+4,870
| New | +$256K |
|
452
Avis
CAR
$5.63B
| $242K | 0.08% |
+6,493
| New | +$228K |
|
453
Visteon
VC
$2.77B
| $239K | 0.08% |
+1,908
| New | +$201K |
|
454
LivaNova
LIVN
$4.3B
| $238K | 0.08% |
+3,591
| New | +$200K |
|
|
NVO
455
Novo Nordisk
NVO
$216B
| $238K | 0.08% |
+6,808
| New | +$235K |
|
456
Zoetis
ZTS
$31.6B
| $238K | 0.08% |
+1,439
| New | +$234K |
|
457
Silgan Holdings
SLGN
$4.91B
| $237K | 0.08% |
+6,401
| New | +$231K |
|
458
Tenable Holdings
TENB
$3.56B
| $237K | 0.08% |
+4,528
| New | +$179K |
|
459
Datadog
DDOG
$87.9B
| $236K | 0.08% |
+2,397
| New | +$239K |
|
460
Intellia Therapeutics
NTLA
$1.5B
| $236K | 0.08% |
+4,334
| New | +$157K |
|
461
Post Holdings
POST
$4.12B
| $236K | 0.08% |
+3,563
| New | +$220K |
|
462
Autoliv
ALV
$8.6B
| $233K | 0.08% |
+2,525
| New | +$218K |
|
|
PS
463
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $233K | 0.08% |
+11,114
| New | +$199K |
|
464
Ameris Bancorp
ABCB
$5.89B
| $232K | 0.08% |
+6,104
| New | +$198K |
|
465
Karyopharm Therapeutics
KPTI
$168M
| $232K | 0.08% |
+1,000
| New | +$232K |
|
466
Synopsys
SNPS
$71.5B
| $232K | 0.08% |
+893
| New | +$206K |
|
467
Viavi Solutions
VIAV
$9.75B
| $232K | 0.08% |
+15,515
| New | +$206K |
|
|
CCXI
468
DELISTED
ChemoCentryx, Inc.
CCXI
| $230K | 0.08% |
+3,709
| New | +$212K |
|
469
MSCI
MSCI
$40B
| $229K | 0.08% |
+513
| New | +$201K |
|
470
Microchip Technology
MCHP
$42.8B
| $225K | 0.08% |
+3,264
| New | +$203K |
|
471
Theravance Biopharma
TBPH
$874M
| $225K | 0.08% |
+12,643
| New | +$227K |
|
472
Toll Brothers
TOL
$14B
| $224K | 0.08% |
+5,152
| New | +$239K |
|
473
CryoPort
CYRX
$775M
| $222K | 0.08% |
+5,061
| New | +$241K |
|
474
Vishay Intertechnology
VSH
$5.86B
| $222K | 0.08% |
+10,723
| New | +$198K |
|
|
DX
475
Dynex Capital
DX
$2.99B
| $221K | 0.08% |
+12,434
| New | +$213K |
|
Similar funds
SCP
MM
P8IP
BWA
MI
TGV
SFCL
AIM
Bridgefront Capital's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Bridgefront Capital, which disclosed 582 positions worth $292M. Its ten largest holdings account for 7.3% of the portfolio.
Its largest position is American Water Works: 19,973 shares worth $3.06M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, followed by Healthcare and Industrials.
- Bridgefront Capital's largest Q4 2020 buy was American Water Works: 19,973 shares worth $3.06M.
- Bridgefront Capital's ten largest holdings make up 7.3% of its $292M portfolio in Q4 2020.
- Bridgefront Capital disclosed 582 positions in Q4 2020, its first 13F filing on record.
Based on Bridgefront Capital's 13F filing for Q4 2020, filed 12 Feb 2021.